According to the p-SHP2 expression from the RPPA examination across TCGA cancers, as illustrated in Supplementary Figure S1, the median of p-SHP2 levels in CRC was located in the front of the list (ranked 12) among 31 cancer types. Here, PTPN11 is linked to cancer.